Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)
HKD 0.14
(1.41%)
HKD 0.14
(1.41%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.41 Billion CNY | -2.25% |
| 2022 | 1.44 Billion CNY | 10.76% |
| 2021 | 1.3 Billion CNY | 16.66% |
| 2020 | 1.12 Billion CNY | -0.29% |
| 2019 | 1.12 Billion CNY | 14.0% |
| 2018 | 986.09 Million CNY | -1.41% |
| 2017 | 1 Billion CNY | -3.23% |
| 2016 | 1.03 Billion CNY | -7.15% |
| 2015 | 1.11 Billion CNY | 10.03% |
| 2014 | 1.01 Billion CNY | 10.67% |
| 2013 | 914.1 Million CNY | 4.98% |
| 2012 | 870.73 Million CNY | 14.37% |
| 2011 | 761.31 Million CNY | -22.76% |
| 2010 | 985.7 Million CNY | 187.02% |
| 2009 | 343.42 Million CNY | 14.81% |
| 2008 | 299.12 Million CNY | -8.18% |
| 2007 | 325.79 Million CNY | 17.47% |
| 2006 | 277.35 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.42 Billion CNY | 0.0% |
| 2024 Q1 | - CNY | -100.0% |
| 2023 Q2 | 1.42 Billion CNY | 0.0% |
| 2023 Q4 | 1.41 Billion CNY | 0.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 FY | 1.41 Billion CNY | -2.25% |
| 2023 Q1 | - CNY | -100.0% |
| 2022 Q2 | 1.33 Billion CNY | 0.0% |
| 2022 Q4 | 1.44 Billion CNY | 0.0% |
| 2022 FY | 1.44 Billion CNY | 10.76% |
| 2022 Q1 | - CNY | -100.0% |
| 2022 Q3 | - CNY | -100.0% |
| 2021 Q2 | 1.24 Billion CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | 1.3 Billion CNY | 16.66% |
| 2021 Q4 | 1.3 Billion CNY | 0.0% |
| 2020 Q2 | 1.08 Billion CNY | 0.0% |
| 2020 FY | 1.12 Billion CNY | -0.29% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q4 | 1.12 Billion CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q2 | 1.03 Billion CNY | 0.0% |
| 2019 Q4 | 1.12 Billion CNY | 0.0% |
| 2019 FY | 1.12 Billion CNY | 14.0% |
| 2018 Q2 | 1 Billion CNY | 0.0% |
| 2018 FY | 986.09 Million CNY | -1.41% |
| 2018 Q4 | 986.09 Million CNY | 0.0% |
| 2018 Q1 | - CNY | -100.0% |
| 2017 Q2 | 1.05 Billion CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 FY | 1 Billion CNY | -3.23% |
| 2017 Q4 | 1 Billion CNY | 0.0% |
| 2016 Q4 | 1.03 Billion CNY | 0.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | 1.03 Billion CNY | -7.15% |
| 2016 Q2 | 991.13 Million CNY | 0.0% |
| 2015 Q2 | 1.03 Billion CNY | 0.0% |
| 2015 Q4 | 1.11 Billion CNY | 0.0% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 1.11 Billion CNY | 10.03% |
| 2014 FY | 1.01 Billion CNY | 10.67% |
| 2014 Q2 | 970.88 Million CNY | 0.0% |
| 2014 Q4 | 1.01 Billion CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2013 Q2 | 912.11 Million CNY | 0.0% |
| 2013 FY | 914.1 Million CNY | 4.98% |
| 2013 Q4 | 914.1 Million CNY | 0.0% |
| 2013 Q1 | - CNY | -100.0% |
| 2012 FY | 870.73 Million CNY | 14.37% |
| 2012 Q4 | 870.73 Million CNY | 0.0% |
| 2012 Q2 | 860.56 Million CNY | 0.0% |
| 2011 Q2 | 924.02 Million CNY | 0.0% |
| 2011 Q4 | 761.31 Million CNY | 0.0% |
| 2011 FY | 761.31 Million CNY | -22.76% |
| 2010 Q2 | 343.8 Million CNY | 0.0% |
| 2010 FY | 985.7 Million CNY | 187.02% |
| 2010 Q4 | 985.7 Million CNY | 0.0% |
| 2009 Q4 | 343.42 Million CNY | 0.0% |
| 2009 FY | 343.42 Million CNY | 14.81% |
| 2008 FY | 299.12 Million CNY | -8.18% |
| 2007 FY | 325.79 Million CNY | 17.47% |
| 2006 FY | 277.35 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | -56.0% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 93.713% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | -9.98% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | 32.431% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -196.088% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | 51.027% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | 49.934% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | 18.045% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -67.738% |
| SSY Group Limited | 11.96 Billion HKD | 88.17% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | -1.941% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 59.4% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 99.479% |